Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.415 HKD | -1.19% | +12.16% | -33.06% |
Apr. 12 | Clover Biopharmaceuticals, Ltd. announced that it has received $0.320713 million in funding | CI |
Apr. 08 | Clover Biopharmaceuticals' RSV Vaccine Candidate Shows Promise in Early Trial | MT |
Sales 2021 | - | Sales 2022 | - | Capitalization | 2.96B 23.1B |
---|---|---|---|---|---|
Net income 2021 | -6.02B -47B | Net income 2022 | -2.45B -19.16B | EV / Sales 2021 | - |
Net cash position 2021 | 2.79B 21.81B | Net cash position 2022 | 1.27B 9.92B | EV / Sales 2022 | - |
P/E ratio 2021 |
-2.13
x | P/E ratio 2022 |
-1.03
x | Employees | 387 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 48.91% |
1 day | -1.19% | ||
1 week | +12.16% | ||
Current month | +20.29% | ||
1 month | +5.06% | ||
3 months | -6.74% | ||
6 months | -46.79% | ||
Current year | -33.06% |
Managers | Title | Age | Since |
---|---|---|---|
Joshua Liang
CEO | Chief Executive Officer | - | 20-12-24 |
Aileen Wang
DFI | Director of Finance/CFO | - | 21-02-28 |
Htay Htay Han
CTO | Chief Tech/Sci/R&D Officer | 56 | 21-02-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Farrow
BRD | Director/Board Member | 62 | 21-04-18 |
Xiao Dong Wang
BRD | Director/Board Member | 61 | 21-03-15 |
Xiao Bin Wu
BRD | Director/Board Member | 62 | 21-04-18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.69% | 4 M€ | -27.92% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.415 | -1.19% | 843,000 |
24-05-09 | 0.42 | +7.69% | 2,291,500 |
24-05-08 | 0.39 | -4.88% | 1,341,831 |
24-05-07 | 0.41 | -2.38% | 1,398,000 |
24-05-06 | 0.42 | -3.45% | 5,154,000 |
Delayed Quote Hong Kong S.E., May 10, 2024 at 04:08 am EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-33.06% | 68.89M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- 2197 Stock